CB1R antagonist increases hepatic insulin clearance in fat-fed dogs likely via upregulation of liver adiponectin receptors

The improvement of hepatic insulin sensitivity by the cannabinoid receptor 1 (CB1R) antagonist rimonabant (RIM) has been recently been reported to be due to upregulation of adiponectin. Several studies demonstrated that improvement in insulin clearance accompanies the enhancement of hepatic insulin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Physiol Endocrinol Metab
Autors principals: Kabir, Morvarid, Iyer, Malini S., Richey, Joyce M., Woolcott, Orison O., Asare Bediako, Isaac, Wu, Qiang, Kim, Stella P., Stefanovski, Darko, Kolka, Cathryn M., Hsu, Isabel R., Catalano, Karyn J., Chiu, Jenny D., Ionut, Viorica, Bergman, Richard N.
Format: Artigo
Idioma:Inglês
Publicat: American Physiological Society 2015
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4609878/
https://ncbi.nlm.nih.gov/pubmed/26306598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpendo.00196.2015
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars